ARTICLE | Company News
Vertex, Novartis deal
November 15, 2004 8:00 AM UTC
Under a 2000 deal that was amended in February, VRTX received a $10 million milestone payment triggered when NVS selected VRTX's VX-322 protein kinase inhibitor for clinical development to treat cance...